195 The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma

BACKGROUND: Bronchial asthma develops by the age of 3 years frequently in childhood in industrialized countries. Pranlukast hydrate, leukotriene receptor antagonists, has been shown to be clinically effective for the treatment of hypersensitivity and childhood asthma. The generic drugs for PLK were...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ogawa, Norifumi, Mikami, Kentaro, Sato, Masahiko, Mezawa, Kenniti, Iwata, Satoshi, Takazawa, Reiko, Oshiba, Akihiro, Hoshioka, Akira, Noma, Takeshi
Format: Artigo
Idioma:Inglês
Publicat: World Allergy Organization Journal 2012
Matèries:
Abstracts of the XXII World Allergy Congress
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3512954/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.WOX.0000411952.04837.57
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars